Ribapharm Inc.
Records under this name other than patents Ribapharm Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,989,451 | Heterocyclic Compounds and Uses Thereof Formerly held Term ended Term ended Jun 4, 2023 · High confidence | Term ended | Term ended Jun 4, 2023 | High confidence |
| US 7,371,857 | Synthesis for Hydroxyalkylated Heterocyclic Bases Formerly held Term ended Term ended Oct 29, 2022 · High confidence | Term ended | Term ended Oct 29, 2022 | High confidence |
| US 7,056,895 | Tirazole Nucleoside Analogs and Methods for Using Same Formerly held Term ended Ended no later than Feb 20, 2021 · Low confidence | Term ended | Ended no later than Feb 20, 2021 | Low confidence |
| US 6,455,508 | Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides Formerly held Term ended Term ended Oct 5, 2020 · From the USPTO record | Term ended | Term ended Oct 5, 2020 | From the USPTO record |
| US 6,573,248 | Monocyclic L-Nucleosides, Analogs and Uses Thereof Term ended Ended no later than Aug 7, 2020 · Low confidence | Term ended | Ended no later than Aug 7, 2020 | Low confidence |
| US 6,815,542 | Nucleoside Compounds and Uses Thereof Formerly held Term ended Term ended Jun 16, 2020 · Medium confidence | Term ended | Term ended Jun 16, 2020 | Medium confidence |
| US 6,518,253 | Treatment of viral infections using the L-isomer of ribavirin Formerly held Term ended Ended no later than Dec 23, 2019 · From the USPTO record | Term ended | Ended no later than Dec 23, 2019 | From the USPTO record |
| US 7,247,621 | Antiviral Phosphonate Compounds and Methods Therefor Formerly held Lapsed on the fee record Ended Jul 24, 2019 · High confidence | Lapsed on the fee record | Ended Jul 24, 2019 | High confidence |
| US 6,403,566 | Nucleosides having bicyclic sugar moiety Formerly held Term ended Term ended May 24, 2019 · From the USPTO record | Term ended | Term ended May 24, 2019 | From the USPTO record |
| US 6,083,482 | Conformationally locked nucleosides and oligonucleotides Formerly held Term ended Term ended May 11, 2019 · From the USPTO record | Term ended | Term ended May 11, 2019 | From the USPTO record |